223 related articles for article (PubMed ID: 22419371)
1. Hodgkin's lymphoma RNA-transfected dendritic cells induce cancer/testis antigen-specific immune responses.
Winkler C; Steingrube DS; Altermann W; Schlaf G; Max D; Kewitz S; Emmer A; Kornhuber M; Banning-Eichenseer U; Staege MS
Cancer Immunol Immunother; 2012 Oct; 61(10):1769-79. PubMed ID: 22419371
[TBL] [Abstract][Full Text] [Related]
2. Expression of HLA-A2 antigen in human melanoma cell lines and its role in T-cell recognition.
Pandolfi F; Boyle LA; Trentin L; Kurnick JT; Isselbacher KJ; Gattoni-Celli S
Cancer Res; 1991 Jun; 51(12):3164-70. PubMed ID: 1904004
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of pre-existent immunity in patients with primary breast cancer: molecular and cellular assays to quantify antigen-specific T lymphocytes in peripheral blood mononuclear cells.
Rentzsch C; Kayser S; Stumm S; Watermann I; Walter S; Stevanoviç S; Wallwiener D; Gückel B
Clin Cancer Res; 2003 Oct; 9(12):4376-86. PubMed ID: 14555509
[TBL] [Abstract][Full Text] [Related]
4. Immune responses to a class II helper peptide epitope in patients with stage III/IV resected melanoma.
Wong R; Lau R; Chang J; Kuus-Reichel T; Brichard V; Bruck C; Weber J
Clin Cancer Res; 2004 Aug; 10(15):5004-13. PubMed ID: 15297401
[TBL] [Abstract][Full Text] [Related]
5. Elicitation of both CD4 and CD8 T-cell-mediated specific immune responses to HCA587 protein by autologous dendritic cells.
Li B; He X; Pang X; Zhang H; Chen J; Chen W
Scand J Immunol; 2004 Nov; 60(5):506-13. PubMed ID: 15541044
[TBL] [Abstract][Full Text] [Related]
6. PRAME-specific Allo-HLA-restricted T cells with potent antitumor reactivity useful for therapeutic T-cell receptor gene transfer.
Amir AL; van der Steen DM; van Loenen MM; Hagedoorn RS; de Boer R; Kester MD; de Ru AH; Lugthart GJ; van Kooten C; Hiemstra PS; Jedema I; Griffioen M; van Veelen PA; Falkenburg JH; Heemskerk MH
Clin Cancer Res; 2011 Sep; 17(17):5615-25. PubMed ID: 21771875
[TBL] [Abstract][Full Text] [Related]
7. Human dendritic cells transfected with either RNA or DNA encoding influenza matrix protein M1 differ in their ability to stimulate cytotoxic T lymphocytes.
Strobel I; Berchtold S; Götze A; Schulze U; Schuler G; Steinkasserer A
Gene Ther; 2000 Dec; 7(23):2028-35. PubMed ID: 11175315
[TBL] [Abstract][Full Text] [Related]
8. Dendritic cells fused with allogeneic colorectal cancer cell line present multiple colorectal cancer-specific antigens and induce antitumor immunity against autologous tumor cells.
Koido S; Hara E; Homma S; Torii A; Toyama Y; Kawahara H; Watanabe M; Yanaga K; Fujise K; Tajiri H; Gong J; Toda G
Clin Cancer Res; 2005 Nov; 11(21):7891-900. PubMed ID: 16278414
[TBL] [Abstract][Full Text] [Related]
9. alpha-fetoprotein and interleukin-18 gene-modified dendritic cells effectively stimulate specific type-1 CD4- and CD8-mediated T-Cell response from hepatocellular carcinoma patients in Vitro.
Cao DY; Yang JY; Dou KF; Ma LY; Teng ZH
Hum Immunol; 2007 May; 68(5):334-41. PubMed ID: 17462500
[TBL] [Abstract][Full Text] [Related]
10. Maturation of dendritic cells and T-cell responses in sentinel lymph nodes from patients with breast carcinoma.
Matsuura K; Yamaguchi Y; Ueno H; Osaki A; Arihiro K; Toge T
Cancer; 2006 Mar; 106(6):1227-36. PubMed ID: 16475148
[TBL] [Abstract][Full Text] [Related]
11. Restoration of tumor-specific HLA class I restricted cytotoxicity in tumor infiltrating lymphocytes of advanced breast cancer patients by in vitro stimulation with tumor antigen-pulsed autologous dendritic cells.
Kass R; Bellone S; Palmieri M; Canè S; Bignotti E; Henry-Tillman R; Hutchins L; Cannon MJ; Klimberg S; Santin AD
Breast Cancer Res Treat; 2003 Aug; 80(3):275-85. PubMed ID: 14503800
[TBL] [Abstract][Full Text] [Related]
12. Specific antihepatocellular carcinoma T cells generated by dendritic cells pulsed with hepatocellular carcinoma cell line HepG2 total RNA.
Zhang L; Zhang H; Liu W; Wang H; Jia J; Si X; Ren J
Cell Immunol; 2005 Nov; 238(1):61-6. PubMed ID: 16472793
[TBL] [Abstract][Full Text] [Related]
13. Common features and differences in the transcriptome of large cell anaplastic lymphoma and classical Hodgkin's lymphoma.
Willenbrock K; Küppers R; Renné C; Brune V; Eckerle S; Weidmann E; Bräuninger A; Hansmann ML
Haematologica; 2006 May; 91(5):596-604. PubMed ID: 16670065
[TBL] [Abstract][Full Text] [Related]
14. Characterization of Ewing sarcoma associated cancer/testis antigens.
Mahlendorf DE; Staege MS
Cancer Biol Ther; 2013 Mar; 14(3):254-61. PubMed ID: 23291981
[TBL] [Abstract][Full Text] [Related]
15. Expression of the Epstein-Barr virus-encoded Epstein-Barr virus nuclear antigen 1 in Hodgkin's lymphoma cells mediates Up-regulation of CCL20 and the migration of regulatory T cells.
Baumforth KR; Birgersdotter A; Reynolds GM; Wei W; Kapatai G; Flavell JR; Kalk E; Piper K; Lee S; Machado L; Hadley K; Sundblad A; Sjoberg J; Bjorkholm M; Porwit AA; Yap LF; Teo S; Grundy RG; Young LS; Ernberg I; Woodman CB; Murray PG
Am J Pathol; 2008 Jul; 173(1):195-204. PubMed ID: 18502823
[TBL] [Abstract][Full Text] [Related]
16. Usage of standardized antigen-presenting cells improves ELISpot performance for complex protein antigens.
Navarrete MA; Bertinetti-Lapatki C; Michelfelder I; Veelken H
J Immunol Methods; 2013 May; 391(1-2):146-53. PubMed ID: 23507194
[TBL] [Abstract][Full Text] [Related]
17. Generation of antigen-presenting cells using cultured dendritic cells and amplified autologous tumor mRNA.
Minami K; Yamaguchi Y; Ohshita A; Kawabuchi Y; Ohta K; Hihara J; Toge T
Oncology; 2005; 69(5):399-407. PubMed ID: 16319511
[TBL] [Abstract][Full Text] [Related]
18. Recognition of Epstein-Barr virus-associated gastric carcinoma cells by cytotoxic T lymphocytes induced in vitro with autologous lymphoblastoid cell line and LMP2-derived, HLA-A24-restricted 9-mer peptide.
Okugawa K; Itoh T; Kawashima I; Takesako K; Mazda O; Nukaya I; Yano Y; Yamamoto Y; Yamagishi H; Ueda Y
Oncol Rep; 2004 Oct; 12(4):725-31. PubMed ID: 15375491
[TBL] [Abstract][Full Text] [Related]
19. Tumor mRNA-transfected dendritic cells stimulate the generation of CTL that recognize neuroblastoma-associated antigens and kill tumor cells: immunotherapeutic implications.
Morandi F; Chiesa S; Bocca P; Millo E; Salis A; Solari M; Pistoia V; Prigione I
Neoplasia; 2006 Oct; 8(10):833-42. PubMed ID: 17032500
[TBL] [Abstract][Full Text] [Related]
20. The generation of LMP2a-specific cytotoxic T lymphocytes for the treatment of patients with Epstein-Barr virus-positive Hodgkin disease.
Su Z; Peluso MV; Raffegerst SH; Schendel DJ; Roskrow MA
Eur J Immunol; 2001 Mar; 31(3):947-58. PubMed ID: 11241300
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
